Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales.

Gregory WestonAbhigya GiriLauren KomarowLizhao GeKeri R BaumErin AbbenanteJason C Gallagher Lindsey B Gottlieb Keith S KayeAngela C KimW Charles HuskinsMarcus J ZervosErica HercRobin Patel David Van Duin Yohei Doi

Published in: The Journal of antimicrobial chemotherapy (2024)

Patients with clinical EORE infection rarely received anti-CRE agents, but attained similar outcomes compared with patients with MCRE infection. The findings support current IDSA treatment guidance for meropenem- or imipenem-based therapy for treatment of EORE infections.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
type diabetes
combination therapy